Cargando…
Radiosensitization in Pediatric High-Grade Glioma: Targets, Resistance and Developments
Pediatric high-grade gliomas (pHGG) are the leading cause of cancer-related death in children. These epigenetically dysregulated tumors often harbor mutations in genes encoding histone 3, which contributes to a stem cell-like, therapy-resistant phenotype. Furthermore, pHGG are characterized by a dif...
Autores principales: | Metselaar, Dennis S., du Chatinier, Aimée, Stuiver, Iris, Kaspers, Gertjan J. L., Hulleman, Esther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047603/ https://www.ncbi.nlm.nih.gov/pubmed/33869066 http://dx.doi.org/10.3389/fonc.2021.662209 |
Ejemplares similares
-
RONC-21. IDENTIFICATION OF EPIGENETIC DRUGS AS RADIOSENSITIZERS IN PEDIATRIC HIGH-GRADE GLIOMAS
por: Metselaar, Dennis, et al.
Publicado: (2020) -
An efficient method for the transduction of primary pediatric glioma neurospheres
por: Meel, Michaël H., et al.
Publicado: (2018) -
Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin
por: Metselaar, Dennis S., et al.
Publicado: (2019) -
AURKA and PLK1 inhibition selectively and synergistically block cell cycle progression in diffuse midline glioma
por: Metselaar, Dennis S., et al.
Publicado: (2022) -
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
por: Meel, Michaël H., et al.
Publicado: (2017)